Advancing Health Equity for Black Men Through Early Detection, Education, and Community Engagement

The Morehouse School of Medicine’s Prostate Cancer Precision Prevention Program (PCP3) is dedicated to reduce outcome variations for men at highest risk for prostate cancer in Georgia and beyond. Through innovative, community-anchored outreach, no cost PSA screenings, and robust partnerships, PCP3 empowers men and their families with knowledge, access, and support for prostate health.

Black men experience the highest incidence of prostate cancer among men in the United States. While 1 in 8 men are expected to be diagnosed with prostate cancer during their lifetime, this number increases to 1 in 6 for Black men. Lack of screening in this high-risk population undoubtedly drive the higher rates of incidence for Black men who are 2.5 times more likely to die from this disease than other men. Given the major public health concerns surrounding outcome variations in men with prostate cancer, it is crucial to include early screening and detection approaches that target untapped communities which have been historically overlooked despite possessing the highest need.

Why PCP3?

Black men face the highest rates of prostate cancer in the U.S.—with 1 in 6 expected to be diagnosed in their lifetime. PCP3 was created to change this narrative by bringing free, accessible screening and education directly to the communities most at risk.

Our Approach

Community-Based Screenings, Mobile Health Unit, Education for All Ages, Data-Driven Impact

Program Highlights

No cost PSA testing and follow-up, culturally tailored education, community partnerships, collaborative network for follow-up care regardless of insurance status